BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Ipca Laboratories Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524494
ISIN Demat
INE571A01038
Book Value (Rs)
314.5139046
NSE Symbol
IPCALAB
Divident Yield %
0.33
Market Cap
(Rs In Cr.)
46,277
P/E (TTM)
40.07
EPS (TTM)
45.52
Face Value
(Rs)
1
Back
Ipca Laboratories consolidated net profit rises 340.98% in the March 2026 quarter
30-May-26   Hrs IST

Net profit of Ipca Laboratories rose 340.98% to Rs 299.07 crore in the quarter ended March 2026 as against Rs 67.82 crore during the previous quarter ended March 2025. Sales rose 6.31% to Rs 2388.48 crore in the quarter ended March 2026 as against Rs 2246.69 crore during the previous quarter ended March 2025.

For the full year,net profit rose 54.69% to Rs 1141.12 crore in the year ended March 2026 as against Rs 737.68 crore during the previous year ended March 2025. Sales rose 7.91% to Rs 9646.33 crore in the year ended March 2026 as against Rs 8939.59 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2388.482246.69 6 9646.338939.59 8
OPM %20.2619.09 -20.5119.31 -
PBDT557.41433.17 29 2077.071734.01 20
PBT450.27333.05 35 1658.951336.19 24
NP299.0767.82 341 1141.12737.68 55

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)